Literature DB >> 27230445

Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor.

Guillaume Chassagnon1, Dominique Hubert2, Isabelle Fajac3, Pierre-Régis Burgel2, Marie-Pierre Revel4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27230445     DOI： 10.1183/13993003.01918-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores.

Authors:  Guillaume Chassagnon; Evangelia I Zacharaki; Sébastien Bommart; Pierre-Régis Burgel; Raphael Chiron; Séverine Dangeard; Nikos Paragios; Clémence Martin; Marie-Pierre Revel
Journal:  Radiol Cardiothorac Imaging       Date:  2020-12-17

Review 2.  CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.

Authors:  Lucile Regard; Clémence Martin; Espérie Burnet; Jennifer Da Silva; Pierre-Régis Burgel
Journal:  Cells       Date:  2022-05-28       Impact factor: 7.666

3.  An automated computed tomography score for the cystic fibrosis lung.

Authors:  Guillaume Chassagnon; Clémence Martin; Pierre-Régis Burgel; Dominique Hubert; Isabelle Fajac; Nikos Paragios; Evangelia I Zacharaki; Paul Legmann; Joel Coste; Marie-Pierre Revel
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

4.  Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation.

Authors:  J S Guimbellot; A Baines; A Paynter; S L Heltshe; J VanDalfsen; M Jain; S M Rowe; S D Sagel
Journal:  J Cyst Fibros       Date:  2020-11-25       Impact factor: 5.482

Review 5.  New Therapies to Correct the Cystic Fibrosis Basic Defect.

Authors:  Christelle Bergeron; André M Cantin
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

6.  Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor.

Authors:  François Arnaud; Nathalie Stremler-Le Bel; Martine Reynaud-Gaubert; Julien Mancini; Jean-Yves Gaubert; Guillaume Gorincour
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

7.  CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.

Authors:  Katherine B Hisert; Timothy P Birkland; Kelly Q Schoenfelt; Matthew E Long; Brenda Grogan; Suzanne Carter; W Conrad Liles; Edward F McKone; Lev Becker; Anne M Manicone; Sina A Gharib
Journal:  Front Pharmacol       Date:  2020-08-13       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.